Copy Link Print Information

Relatlimab

(Synonyms: BMS-986016)
4 Cited Publications
Avis client

Based on 4 publication(s) in Google Scholar

Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté : 98.00%
  • CAS No.: 1673516-98-7
  • Masse moléculaire:145.58 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Experimental Validation Results for Relatlimab
  • Relatlimab Chemical Structure
    Relatlimab Chemical Structure
CAS No.: 1673516-98-7
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Relatlimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Relatlimab

More
Customer Validation & Images
Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay

Keywords

MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 kappa

  • 1/16

    Flow cytometric analysis of 1X106 Jurkat cells with Relatlimab (HY-P99156, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Loaded Relatlimab on AHC2 biosensor, can bind LAG-3 Protein, Human (HEK293, His, HY-P70722) with an affinity constant of 8.814E-10 M as determined in BLI assay.

  • 1/16

    Relatlimab purchased from MedChemExpress. Usage Cited in: Cell. 2025 Jul 24;188(15):4025-4042.e20. [Abstract]

    Customer Validation
     In the presence of HLA-DR1 HA306-318 aAPC, Relatlimab (anti-LAG-3) (20 μg/mL; 75 μL; 30 min; 37 ℃) reversed the LAG-3 overexpression-induced suppression of GFP reporter signal in human LAG-3-transduced Jurkat NFAT-GFP reporter T cells.

  • 1/16

    Relatlimab purchased from MedChemExpress. Usage Cited in: Cell. 2025 Jul 24;188(15):4025-4042.e20. [Abstract]

    Customer Validation
     Relatlimab (anti-LAG-3) (20 μg/mL; 75 μL; 30 min; 37 ℃) blocked the LAG-3 CAR signal triggered by human pMHC class II.

  • 1/16

    Relatlimab purchased from MedChemExpress. Usage Cited in: Cell. 2025 Jul 24;188(15):4025-4042.e20. [Abstract]

    Customer Validation
     Relatlimab (anti-LAG-3) (80 nM). The percentage of mCherry+ Lck and TCR-CD3 measured by anti-CD3ε antibody (OKT3, Alexa-647 labeled) co-localized with each other, and the number or size of the TCR clusters.

  • 1/16

    Relatlimab purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2025 Feb 10;11(1):58. [Abstract]

    Customer Validation
     Relatlimab (1-100 nM) showed significant binding to recombinant LAG-3/Fc.

  • Relatlimab Chemical Structure
    1/16
  • Relatlimab
  • Flow cytometric analysis of 1X106 Jurkat cells with Relatlimab (HY-P99156, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Loaded Relatlimab on AHC2 biosensor, can bind LAG-3 Protein, Human (HEK293, His, HY-P70722) with an affinity constant of 8.814E-10 M as determined in BLI assay.